Background: The emergence of real-time glucose sensors for people with diabetes may replace discontinuous monitoring (self-monitored blood glucose [BG]) in the future. In this study, we use a computer-generated "virtual" patient to predict changes in behavior that may result from an increased awareness of BG levels.

Methods: The employed strategy required educated patients with type 1 diabetes to simulate a virtual patient using the DIABLOG Scientific simulator, interactive computer program. Thirty patients with a mean age of 34 years and duration of diabetes of 18 years (15 with continuous subcutaneous insulin infusion, 15 with intensive conventional therapy) simulated several daily glucose profiles with conventional self-monitoring of BG, using the time-lapse function of the program. Thereafter they had access to the actual glucose value either in a watch-type display or in a graphical display. Behavioral changes were monitored and stored.

Results: Mean BG value improved from 154 to 139 mg/dL (P < 0.05). The analysis of the process and behavioral changes revealed that patients recognized an impending hypoglycemia with the sensor in 94% of cases (59% without sensor) and reacted adequately in 98% of cases in order to avoid hypoglycemia. The frequency of hypoglycemia could be reduced from 1.7 per week to 0.5 per week. Unnecessary interventions (mostly by administration of carbohydrates) doubled to 3.2 per week using the continuous measurement system. Impending hyperglycemia could only be prevented in 25% of cases without a sensor, and with sensor this ratio could only be marginally improved to 29%. Supplementary insulin administration resulted in hypoglycemia only in a few cases.

Conclusions: With the continuous measurement of their actual BG, subjects could reduce the frequency of hypoglycemia by 50% but increased the number of unnecessary interventions (excess carbohydrate intake or prematurely without a real hypoglycemia threat). Hyperglycemia prevention is a more difficult task. Simulation with an in silico disease model is a realistic alternative to studies in patients. A simulation program such as DIABLOG could be valuable for education in order to more rapidly and reliably recognize impending hypo- and hyperglycemia episodes.

Download full-text PDF

Source
http://dx.doi.org/10.1089/dia.2007.0281DOI Listing

Publication Analysis

Top Keywords

blood glucose
8
"virtual" patient
8
behavioral changes
8
frequency hypoglycemia
8
unnecessary interventions
8
continuous measurement
8
hypoglycemia
6
patients
5
glucose
5
patients behave
4

Similar Publications

Modulation of placental angiogenesis by metformin in a rat model of gestational diabetes.

Histochem Cell Biol

January 2025

Medical Histology and Cell Biology Department, Faculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.

Gestational diabetes mellitus (GDM) significantly disrupts placental structure and function, leading to complications such as intrauterine growth restriction (IUGR) and preeclampsia. This study aimed to investigate the effects of GDM on placental histology, angiogenesis, and oxidative stress, as well as evaluate metformin's protective role in mitigating these changes. A total of 60 pregnant Sprague-Dawley rats were divided into four groups: control, metformin-treated, GDM, and GDM with metformin.

View Article and Find Full Text PDF

Background: The gap between 2-hour post-load plasma glucose (2 h PG) and fasting blood glucose (FBG) has been shown to be informative of the risk of developing prediabetes and diabetes. We aimed to examine the significance of the gap between 2 h PG and FBG in relation to all-cause or cardiovascular disease (CVD) mortality in normoglycemic adults.

Methods: 3611 normoglycemic participants from the 2005-2016 US National Health and Nutrition Examination Survey were included and dichotomized into the low (2 h PG ≤ FBG) and high post-load (2 h PG > FBG) groups.

View Article and Find Full Text PDF

Patients with diabetes are at increased risk of HBV infection; however, the effects of HBV infection and anti-HBV therapy on the management of type 1 diabetes (T1D), type 2 diabetes (T2D), and latent autoimmune diabetes in adults (LADA) remain unclear. From 2016 to 2023, we recruited a multicenter cohort of 355 HBV-infected inpatients, including 136 with T1D, 140 with T2D, and 79 with LADA. The control group included 525 HBV-uninfected inpatients, comparing 171 with T1D, 204 with T2D and 150 with LADA.

View Article and Find Full Text PDF

Background: The differential impact of serum lipids and their targets for lipid modification on cardiometabolic disease risk is debated. This study used Mendelian randomization to investigate the causal relationships and underlying mechanisms.

Methods: Genetic variants related to lipid profiles and targets for lipid modification were sourced from the Global Lipids Genetics Consortium.

View Article and Find Full Text PDF

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a well-known red blood cell enzymopathy and a cause of intravascular hemolysis. This case report presents a child with underlying G6PD deficiency who experienced an acute episode of extensive intravascular hemolysis induced by a scrub typhus infection. The key takeaway from this report is that scrub typhus infection can trigger extensive hemolysis in patients with even "mild" G6PD deficiency, and normal G6PD levels found during the acute phase of hemolysis do not rule out the possibility of underlying G6PD deficiency.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!